Navigation Links
Simcere Pharmaceutical Group Announces SFDA Approval of First-to-Market Generic Biapenem Injection Anxin
Date:5/14/2008

NANJING, China, May 14 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical Group (NYSE: SCR), a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endu in China, today announced that it has received approval from the Chinese State Food and Drug Administration (SFDA) to manufacture and market a first- to-market generic Biapenem injection under the brand name Anxin.

Anxin is the first Biapenem injection approved for sale in China, and will be used for the treatment of serious infections. Biapenem is a member of the fast-growing carbenicillin family, like Tienam from Merck & Co. Inc. and Mepem from Sumitomo Pharmaceuticals Co. Ltd., with a potential market in China of RMB1.6 billion. This family of drug has seen an approximate 30% year over year growth rate in China over the last three years. As is the case with first-to- market branded generics in China, Anxin will enjoy an exclusive four-year market monitoring period, during which the SFDA will not accept further requests for approval of pharmaceuticals with the same chemical structure, dosage form and indication, that have not yet entered into clinical trial.

Mr. Jinsheng Ren, Chairman and Chief Executive Officer of Simcere, commented, "The approval of Anxin, a Simcere developed Biapenem injection, strengthens the company's antibiotic product portfolio in line with our strategy to focus on first-to-market generic and innovative drugs. More importantly, it provides a new and effective treatment for patients with serious infections who have experienced resistance to other antibiotics."

About Simcere Pharmaceutical Group

Simcere Pharmaceutical Group (NYSE:

SOURCE Simcere Pharmaceutical Group
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
3. Simcere Pharmaceutical Group to Announce Fourth Quarter 2007 Earnings on Tuesday, March 4, 2008
4. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2007 Results
5. Simcere Pharmaceutical Group Announces Participation in Brean Murray Carret & Co.s Fourth Investor Tour of China
6. Simcere Pharmaceutical Group to Announce First Quarter 2008 Earnings on Tuesday, May 6, 2008
7. Simcere Pharmaceutical Group Acquires 70% Stake in Wuhu Zhong Ren Pharmaceutical Co. Ltd.
8. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
11. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... 23, 2014 “BlackVue” was featured on ... , which features the latest and coolest technology products ... reporter for NewsWatch, conducted the product review and shared ... powerful options in the car camera industry. , The ... can be hard to find the one that’s right ...
(Date:11/23/2014)... 23, 2014 BambooFlooringChina.com , the world’s ... click strand woven bamboo flooring collection. Now, the business ... the company’s CEO, the promotion is valid until Dec. 20, ... with a smooth and dust-free surface, which makes it very ... the industry, the company wants to make its website the ...
(Date:11/22/2014)... (PRWEB) November 23, 2014 Cancer researchers ... a connection between intercellular communication tunnels and the growth ... the full story on the Surviving Mesothelioma website. ... and the University of Minnesota have just released their ... information and materials between cells. They found that ...
(Date:11/22/2014)... Recently, Locks-Magnetic.com , one of the ... of mag locks for glass doors online. In addition, ... these fresh products. Customers can get more information on ... are in excellent performance. Customers who want to buy ... as possible. They also can enjoy the one-stop ...
(Date:11/22/2014)... 2014 “Due to my knee replacement surgery, ... Gurnee, Ill. “While using the ice grip attachment, I noticed ... there needed to be a safer way to prevent possible ... , The SPIKE BLOCK offers added safety and stability in ... to reduce injuries and damage associated with traditional spiked ice ...
Breaking Medicine News(10 mins):Health News:A Leader in Front and Rear Facing In-Car Cameras was Featured on NewsWatch Television on October 30, 2014 2Health News:Click Strand Woven Bamboo Flooring From Famous Bamboo Flooring Company BambooFlooringChina.com 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2Health News:Discounted Mag Locks for Glass Doors Revealed by Locks-Magnetic.com 2
... , , , , WASHINGTON, Sept. 1 , ... cirrhosis that costs the nation,s health system hundreds of, ... public, attention. As many as 2 million ... chronic hepatitis B and an estimated 3.2 million are, ...
... , , LOUISVILLE, Colo., ... suppliers to enable the healthcare industry to utilize the GS1 industry ... in transactions through the GHX exchange, which is a key component ... With guidance from members of the GHX industry standards user group, ...
... Time , , ATLANTA, Sept. 1 /PRNewswire/ - ... point. The country is now embroiled in a spirited ... medical device, diagnostic, biopharmaceutical, healthcare information system, and service ... , At this critical junction and in the midst ...
... 1, 2009Patients with advanced illnesses more than doubled their ... plan made hospice care more readily accessible, according to ... Journal of Palliative Medicine , a peer-reviewed publication from ... Palliative Medicine is the official journal of the ...
... is available in French . Montreal, September ... biotransformed with bacteria from the skin of the fruit, holds ... published in the International Journal of Obesity , was ... Armand-Frappier and the Universit de Moncton who tested the effects ...
... , , SEARCY, Ark., Sept. 1 ... Foundation will celebrate this year,s National Day of Encouragement with the ... of today,s youth. The tour will launch September 5 in San ... $5,000 college scholarship and commemoration of the third annual National Day ...
Cached Medicine News:Health News:National Summit on Viral Hepatitis to be Held September 10-11 in Washington, D.C. 2Health News:National Summit on Viral Hepatitis to be Held September 10-11 in Washington, D.C. 3Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 2Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 3Health News:GHX Working with Hospitals and Suppliers to Enable Use of Industry Standard Location and Organization Identifiers in Transactions and Compliance with GLN Sunrise Date 4Health News:7th Annual Healthcare M A and Business Development Conference, September 9-10, 2009, Atlanta, GA 2Health News:Expanded insurance benefits break down barriers to hospice care, according to new study 2Health News:Biotransformed blueberry juice fights fat and diabetes 2Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 2Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 3Health News:'7 Days Across America' Campaign Honors Teens Making a Difference in Their Communities 4
(Date:11/21/2014)... N.Y. , Nov. 21, 2014  Cardinal Health, ... world,s largest health care services companies, and Henry Schein, ... provider of health care products and services to office-based ... the companies have entered into a long-term strategic agreement ... product offerings to office-based medical practices.  This strategic agreement ...
(Date:11/21/2014)... MOUNT BRYDGES, Ontario , Nov. 20, 2014 ... workstations, monitor mounting solutions and reading room environment ... implement their newest musculoskeletal radiology reading room, which ... reading room designs at Penn Medicine. ... care by the American College of Radiology,s Imaging ...
(Date:11/21/2014)... , Nov. 20, 2014 Depomed, Inc. (NASDAQ: ... the Piper Jaffray 26 th Annual Healthcare Conference in ... the Piper Jaffray conference is scheduled for 8:00 am EST (5:00 ... webcast, and the webcast can be accessed via the Investor Relations ... of the webcast will be archived for 30 days on the ...
Breaking Medicine Technology:Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 2RedRick Technologies Helps Penn Radiology Implement New Radiology Reading Room Concepts 3Depomed To Present At Piper Jaffray 26th Annual Healthcare Conference 2
... and OSAKA, Japan, February 23, 2011 Takeda ... Global Research & Development Center, Inc. U.S., submitted ... Food and Drug Administration (FDA) for an investigational ... for the treatment of hypertension, or high blood ...
... MORRISTOWN, N.J., Feb. 23, 2011 Watson Pharmaceuticals, Inc. ... company, announced today that Paul Bisaro, Watson,s President and ... of the Company,s business at the 2011 Citi Global ... at 1:30 p.m. (EST). The presentation will be webcast ...
Cached Medicine Technology:Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 2Takeda Submits New Drug Application in the U.S. for Azilsartan Medoxomil Plus Chlorthalidone, an Investigational Fixed-Dose Combination for the Treatment of Hypertension 3
For the quantitative in vitro determination of Anti-Streptolysin-O (ASO) in serum...
Latex agglutination slide test for the qualitative and semi-quantitative determination of Anti-Streptolysin O (ASO) in human serum...
For the quantitative in vitro determination of IgA in serum and plasma. This product is suitable for use on Hitachi 704, 705, 717, 902, 911 and 912....
For the quantitative in vitro determination of total protein in urine and c.s.f....
Medicine Products: